A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Celecoxib Impurity 24 | CAS 90829-71-3 - Request Quote

Picture of Celecoxib Impurity 24

Celecoxib Impurity 24

SZ CAT No:SZ-C005036
CAS No
90829-71-3
Mol.F.
C6H7N3O2S
Mol.Wt.
185.2
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Celecoxib Impurity 24 is chemically 4-Diazenylbenzenesulfonamide. Celecoxib Impurity 24 is supplied with detailed characterization data compliant with regulatory guideline. Celecoxib Impurity 24 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Celecoxib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 90829-71-3

Purchase 90829-71-3

Order 90829-71-3

Enquire 90829-71-3

price of 90829-71-3

90829-71-3 Supplier

90829-71-3 Manufacturer

90829-71-3 Exporter

buy high quality Celecoxib Impurity 24

Purchase Celecoxib Impurity 24

Celecoxib Impurity 24 suppliers

Celecoxib Impurity 24 manufacturers

Celecoxib Impurity 24 price

Order Celecoxib Impurity 24

Enquire Celecoxib Impurity 24

Celecoxib Impurity 24 cost

Celecoxib Impurity 24 Supplier

Celecoxib Impurity 24 Distributor

Celecoxib Impurity 24 for Method Validation

Celecoxib Reference Standard

Celecoxib Impurity 24 for ANDA Filing

Celecoxib Impurity 24 for Forced Degradation Studies

Celecoxib Impurity 24 Identification Standards

Celecoxib Impurity 24 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,